These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 23136768)

  • 21. Permeability of endothelial barrier: cell culture and in vivo models.
    Garcia AN; Vogel SM; Komarova YA; Malik AB
    Methods Mol Biol; 2011; 763():333-54. PubMed ID: 21874463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of indoxyl sulfate on adherens junctions of endothelial cells and the underlying signaling mechanism.
    Peng YS; Lin YT; Chen Y; Hung KY; Wang SM
    J Cell Biochem; 2012 Mar; 113(3):1034-43. PubMed ID: 22213462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rho and ROCK signaling in VEGF-induced microvascular endothelial hyperpermeability.
    Sun H; Breslin JW; Zhu J; Yuan SY; Wu MH
    Microcirculation; 2006; 13(3):237-47. PubMed ID: 16627366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Peptide inhibitors of myosin light chain kinase. Development of peptidase resistant analogues].
    Sekridova AV; Sidorova MV; Az'muko AA; Molokoedov AS; Bushuev VN; Marchenko AV; Shcherbakova OV; Shirinskiĭ VP; Bespalova ZhD
    Bioorg Khim; 2010; 36(4):498-504. PubMed ID: 20823918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A strategy to identify stable membrane-permeant peptide inhibitors of myosin light chain kinase.
    Owens SE; Graham WV; Siccardi D; Turner JR; Mrsny RJ
    Pharm Res; 2005 May; 22(5):703-9. PubMed ID: 15906163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion of myosin light chain kinase in endothelial cells has a minor effect on the lipopolysaccharide-induced increase in microvascular endothelium permeability in mice.
    Yu Y; Lv N; Lu Z; Zheng YY; Zhang WC; Chen C; Peng YJ; He WQ; Meng FQ; Zhu MS; Chen HQ
    FEBS J; 2012 Apr; 279(8):1485-94. PubMed ID: 22353598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro analyses of endothelial cell permeability.
    Monaghan-Benson E; Wittchen ES
    Methods Mol Biol; 2011; 763():281-90. PubMed ID: 21874459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viable "Haemophilus somnus" induces myosin light-chain kinase-dependent decrease in brain endothelial cell monolayer resistance.
    Behling-Kelly E; McClenahan D; Kim KS; Czuprynski CJ
    Infect Immun; 2007 Sep; 75(9):4572-81. PubMed ID: 17591789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MS-681a, b, c and d, new inhibitors of myosin light chain kinase from Myrothecium sp. II. Physico-chemical properties and structure elucidation.
    Ikuina Y; Bando C; Yoshida M; Yano H; Saitoh Y
    J Antibiot (Tokyo); 1997 Dec; 50(12):998-1006. PubMed ID: 9510905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure determination of MS-444; a new myosin light chain kinase inhibitor.
    Aotani Y; Saitoh Y
    J Antibiot (Tokyo); 1995 Sep; 48(9):952-3. PubMed ID: 7592061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Atherosclerosis- and Diabetes-Related Dicarbonyls on Vascular Endothelial Permeability: A Comparative Assessment.
    Samsonov MV; Khapchaev AY; Vorotnikov AV; Vlasik TN; Yanushevskaya EV; Sidorova MV; Efremov EE; Lankin VZ; Shirinsky VP
    Oxid Med Cell Longev; 2017; 2017():1625130. PubMed ID: 29098058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Penetrating peptide inhibitor of the myosin light chain kinase suppresses hyperpermeability of vascular endothelium].
    Marchenko AV; Sidorova MV; Sekridova AV; Bushuev VN; Lakomkin VL; Orlova TsR; Stepanova OV; Kapel'ko VI; Watterson DM; Van Eldik LJ; Bespalova ZhD; Shirinskiĭ VP
    Ross Fiziol Zh Im I M Sechenova; 2009 May; 95(5):507-15. PubMed ID: 19569527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimum requirements for inhibition of smooth-muscle myosin light-chain kinase by synthetic peptides.
    Hunt JT; Floyd DM; Lee VG; Little DK; Moreland S
    Biochem J; 1989 Jan; 257(1):73-8. PubMed ID: 2920029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A role for long chain myosin light chain kinase (MLCK-210) in microvascular hyperpermeability during severe burns.
    Reynoso R; Perrin RM; Breslin JW; Daines DA; Watson KD; Watterson DM; Wu MH; Yuan S
    Shock; 2007 Nov; 28(5):589-95. PubMed ID: 17577141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Suppression of vascular endothelium hyperpermeability by cell-permeating peptide inhibitors of myosin light chain kinase].
    Khapchaev AIu; Samsonov MV; Kazakova OA; Vilitkevich EL; Sidorova MV; Az'muko AA; Molokoedov AS; Bespalova ZhD; Shirinskiĭ VP
    Biofizika; 2012; 57(5):764-70. PubMed ID: 23136768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Novel peptide inhibitors of the myosin light chain kinase suppress hyperpermeability of vascular endothelium].
    Marchenko AV; Stepanova EO; Sekridova AV; Sidorova MV; Bushuev VN; Bespalova ZhD; Shirinskiĭ VP
    Biofizika; 2010; 55(6):1008-13. PubMed ID: 21268344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of peptidase-resistant peptide inhibitors of myosin light chain kinase.
    Khapchaev AY; Kazakova OA; Samsonov MV; Sidorova MV; Bushuev VN; Vilitkevich EL; Az'muko AA; Molokoedov AS; Bespalova ZD; Shirinsky VP
    J Pept Sci; 2016 Nov; 22(11-12):673-681. PubMed ID: 27699916
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.